Company: REVB
Filing Date: 2025-06-09
Form Type: DEF 14A
Source: 0000950170-25-083815
Chunk: 1

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-06-09
Form: DEF 14A
Chunk 1
---
 Passcode 014030 . The purpose of the Annual Meeting will be to consider and vote upon the following proposals: 1. To elect one (1) Class C director of the Company to serve until the 2028 Annual Meeting of Stockholders or until their successors have been duly elected and qualified; 2. To approve an amendment to the 2021 Equity Incentive Plan to adjust the number of shares reserved under the Plan under its “evergreen” feature quarterly rather than annually; 3. To approve, on an advisory basis, the compensation of the Company’s named executive officers and directors; 4. To approve, on an advisory basis, the frequency of three years for future advisory votes on executive compensation; 5. To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation one or more times to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-two to a maximum of a one-for-250 split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock splits, if at all, within one year of the date the proposal is approved by stockholders; 6. To approve the reservation and issuance of shares of our common stock pursuant to Class H Common Stock Warrants (the “Warrants”), dated May 29. 2025, entered into and between us and certain purchasers in connection with a Stock Purchase Agreement dated the same date, to the extent that the issuances under the Warrants might exceed 20% of the Company’s total outstanding shares, which could trigger the share issuance cap under Rule 5635(d) of the Nasdaq Stock Market Rules (the “Exchange Cap”); 7. To approve the change of domicile of the Company from the State of Delaware to the State of Nevada; 8. To ratify the selection by the Audit Committee of the Board of Directors of Baker Tilly US, LLP as the independent auditor of the Company for its fiscal year ending December 31, 2025; and 9. To conduct any other business properly brought before the meeting. The Board of Directors has fixed the close of business on May 29, 2025 as the record date for the Annual Meeting and only holders of shares of record at that time will be entitled to notice of and to vote at the Annual Meeting or any adjournment or adjournments